swot-logo

Aurinia Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aurinia Pharmaceuticals Inc has 28 Strengths, 5 Weaknesses, 0 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

High DVM Mid and Small Caps (subscription)

Strong Performer, Getting Expensive (DVM)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Big Gainers in Share Price with Good Net Profit Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

New 52 week high today

Relative Outperformance versus Industry over 10 Years

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Companies with Net Profit TTM 5X that of Net Profit in Previous Year

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Annual Net Profits improving for last 2 years

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter